The destigmatization of GLP-1 medications in 2024 has also opened the doorway for new categories in beauty and wellness
L.Furuya-KanamoriL.DoiS
Post-marketing surveillance and FDA Adverse Event Reporting System (FAERS) data have documented isolated reports of patients experiencing dyspnea while taking GLP-1 medications, but establishing causality remains challenging
A tissue microarrays containing a total of 204 metastatic melanomas (71 lymph nodes, 55 skin, 33 brain, 15 lung, 14 small bowel, 6 liver, 4 parotid, 2 bone, 2 nasal sinus, 1 breast, and 1 spleen) from the same number of patients were collected from the Department of Pathology at La Timone Hospital (Marseille, France)
Lake Pleasant recovery IV protocol: why 8 hours on the boat drains you harder than you think, and how to plan IV hydration for the morning after